Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex

International Journal of Cardiology

Volumn 54, Issue 2, 1996, Pages 113-116

  Limas, Constantinos J ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Autoantibodies; Autoimmunity; Cytokines; Dilated cardiomyopathy; Major histocompatibility complex; T cell receptor

Indexed keywords

AUTOANTIBODY; BETA ADRENERGIC RECEPTOR; ENDOGENOUS COMPOUND; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; HEART DILATATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029887245     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02587-9     Document Type: Article

References (29)

1. Smith SC, Allen PM. Myosin-induced myocarditis is a T-cell mediated disease. J Immunol 1991; 147: 2141-2147.
2. Neu N, Ploier B, Ofuer C. Cardiac myosin induced myocarditis heart antibodies are not involved in the induction of the disease. J Immunol 1990; 145: 4094-4100.
3. Liao L, Sindhwani R, Leinward L, Diamond B, Factor S. Cardiac α-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes. J Clin Invest 1993; 90: 2877-2882.
4. Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 181: 1123-1131.
5. Bach J-F. Organ-specific autoimmunity. Immunol Today 1995; 16: 353-355.
6. Brocke S, Brautbar C, Steinman L et al. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest 1988; 82: 1894-1900.
7. Bortman G, Sellanes M, Odell DS, Ring WS, Teresa-Olivari MT. Discrepancy between pre- and post-transplantation diagnosis of end-stage dilated cardiomyoapthy. Am J Cardiol 1994; 74: 921-924.
8. Limas CJ, Limas C, Kubo SH, Olivari MT. Anti-beta-receptor antibodies in human dilated cardiomyopathy. Correlation with the HLA-DR antigens. Am J Cardiol 1990; 65: 483-487.
9. Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 918-920.
10. Limas CJ, Limas C. HLA-DR antigen linkage of anti-β-receptor antibodies in idiopathic dilated and ischemic cardiomyopathy. Br Heart J 1992; 67: 402-405.
11. Reveille JD, Owerbach D, Goldestien R, Morela R, Isern RA, Arnett FC. Association of polar amino acids at position 26 of the HLA-DQβ1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 1992; 89: 1208-1213.
12. Caforio ALP, Martinetti M, Schwarz E, Bonifacio E, Uarazzi A, Graziano U, Lorini R, Cuccia M, McKenna WJ, Bottazzo OF. Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992; 39: 236-240.
13. Seyfried CE, Mickelson E. Hansen JA, Nepom GJ. A specific nucleotide sequence defines a functional T-cell recognition epitope shared by diverse HLA-DR specificities. Hum Immunol 1988; 21: 289-2899.
14. Caforio ALP, Bonifacio E, Stewart JT et al. Novel ogan-specific circulating cardiac autoantibodies in dilated cardiomyopathy. JACC 1990; 15: 1527-1534.
15. Neumann DA, Burek CL, Baughman KL et al. Circulating heart-reactive antibodies in patients with myocarditis or myocardiopathy. JACC 1990; 16: 839-846.
16. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoreceptor in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
17. Limas CJ, Goldenberg IF, Limas C. Effect of cardiac transplantation on anti-beta-receptor antibodies in idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 1134-1137.
18. Magnusson Y, Mazullo S, Hoter S et al. Mapping of a functional autoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658-1663.
19. Rada T, Okrahlikova L, Monosikova R et al. Levels of autoantibodies against β-adrenergic receptors and mitochondrial in sera of cardiopathic patients estimatd by ELISA method. Basic Res Cardiol 1992; 87: 80-88.
20. Schultheiss HP, Bolte HD. Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603-617.
21. Klein R, Maisch B, Kolchsiek K, Berg PA. Demonstration of organ-specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart disease. Clin Exp Immunol 1984; 58: 283-292.
22. Graber HL, Unverferth DR, Baker PR, Ryan JM, Baba N, Wooley CF. Evaluation of a hereditary conduction and muscle disorder. A study involving a family with six generations affected. Circulation 1986; 741: 21-35.
23. Limas C, Limas CI, Boudoulas H, Graber H, Bair R, Sparks L, Wooley CF. T-cell receptor gene polymorphisms in familial cardiomyopathy. Correlation with anti-β-receptor autoantibodies. Am Heart J 1992; 124: 1258-1263.
24. Limas CJ, Boudoulas H, Limas C, Graber H, Sparks L, Wooley CF. Antibeta-receptor antibodies in familial cardiomyopathy. Correlation with HLA-DR and -DQ gene polymorphisms. Am J Heart 1994; 127: 382-386.
25. Ota M, Seki T, Nomura N et al. Modified PCR-RFLP method for HLA-DQB1 and DQA1 genotyping. Tissue Antigens 1991; 38: 60-71.
26. Limas C, Limas CJ, Boudoulas H, Bair R, Sparks LN, Graber H, Wooley CF. HLA-DQA1 and DQB1 gene haplotypes in familial cardiomyopathy. Am J Cardiol 1994; 74: 510-572.
27. Limas CJ, Limas C, Goldenberg IF, Blair R. Possible involvement of the HLA-DQβ1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J 1995; 129: 1141-1144.
28. Mason JW, O'Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-275.
29. Hanawa H, Kodama M, Inomata T, Izumi T, Shibata A, Tuchida M, Matsumoto Y, Abo T. Anti-alpha beta T-cell receptor antibody prevents the progression of experimental autoimmune myocarditis. Clin Exp Immunol 1994; 96: 470-475.